研究：業績

【2014】国際学会

• Utah Cardiac Recovery Symposium (U-CARS)
  (2014年1月, Salt Lake City, USA)
• Ichiki T, Schirger JA, Huntley BK, Brozovich FC, Maleszewski JJ, Sandberg SM, Sangaralingham SJ, Park SJ, and Burnett, JC, Jr.
• Cardiac Fibrosis in End-stage Heart Failure and with LVAD Support: Impact on Endogenous Cardiac Natriuretic Peptide System and Modulating Actions of a Novel Designer Natriuretic Peptide In Vitro.
• ACC 63rd. Annual Scientific Session
  (2014年3月, Washington DC)
• Kawasoe S, Miyata M, Kubozono T, Shinsato T, Ohishi M.
• Prognostic Power of Combined Assessment of Red Cell Distribution Width and B-type Natriuretic Peptide in Patients with Chronic Heart Failure.
• 39th World Congress of International Scientific Meeting of Medical Hydrology and Climatology
  (2014年5月, Kyoto, Japan)
• Miyata M, Akasaki Y, Miyauchi T, Ikeda Y, Ohishi M.
• Preventive effect of thermal therapy on heart failure due to pressure overload.
• Pulse of Asia 2014
  (2014年6月, Athens, Greece)
• Akasaki Y, Miyauchi T, Kubozono T, Miyata M, Ohishi M.
• Increased arterial stiffness assessed by brachial-ankle pulse wave velocity is an independent risk factor of left ventricular diastolic dysfunction.
• Miyauchi T, Arimura H, Akasaki Y, Kubozono T, Miyata M, Nishio Y, Ohishi M.
• Strong correlation between IGF-1 and brachial-ankle pulse wave velocity after transsphenodial surgery.
• Joint Meeting Europian Society of Hypertension and International Society Hypertension
  (2014年6月, Athens, Greece)
• Akasaki Y, Miyauchi T, Kubozono T, Miyata M, Ohishi M.
• Increased arterial stiffness assessed by cardio-ankle vascular index is an independent risk factor of left ventricular diastolic dysfunction.
• Miyauchi T, Arimura H, Akasaki Y, Kubozono T, Miyata M, Nishio Y, Ohishi M.
• Changes of cardiovascular disease parameters in patients with acromegaly after transsphenodial surgery.
• AHA Basic Cardiovascular Science (BCVS)
  (2014年7月, Las Vegas, USA)
• Ikeda Y, Zhai P, Ohishi M, Sadoshima J.
• Heterozygous disruption of Drp1 enhances myocardial injury in response to ischemia/reperfusion via inhibition of mitophagy.
• European Society of Cardiology (ESC) Congress 2014
  (2014年8月, Barcelona, Spain)
• Ichiki T, Harty GJ, Sangaralingham SJ, Anderson IA, Huntley BK, Sandberg SM, Heublein DM, and Burnett, JC, Jr.
• Pro-atrial natriuretic peptide1-126: a novel guanylyl cyclase-A activator with selective renal enhancing and cardiac unloading properties which goes beyond carperitide and nesiritide.
• Sangaralingham SJ, Ichiki T, McKie PM, Scott CG, Heublein DM, Chen HH, Redfield MM, Rodeheffer RJ, and Burnett JC, Jr.
• The clinical utility of the novel endothelium-derived biomarker C-type natriuretic peptide for predicting myocardial infarction in the general community.
• Yoshino S, Hamasaki S, Takumi T, Kanda D, Tokushige A, Miyata M, Ohishi M.
• Atrial fibrillation impairs coronary endothelial function on microvascular level in patients with normal or mildly diseased coronary arteries.
• Ueya N, Yuasa T, Horizoe Y, Chaen H, Kubota K, Takasaki K, Mizukami N, Kisanuki A, Ohishi M.
• Right ventricular end diastolic wall stress correlates with plasma B-type natriuretic peptide level in patients with pulmonary hypertension.
• Kajiya T, Wai KL, Tai BC, Lee CH, Chan KH, Tay E, Richards AM, Tan HC, Low AF, Chan MY.
• Interaction between access site and antithrombotic therapy and impact on bleeding outcomes in STEMI.
• Kajiya T, Low AF, Tan HC, Poh KK.
• Left main percutaneous coronary intervention (PCI) improves LV systolic function by tissue doppler imaging (TDI) echocardiography.
• Tokushige A, Shiomi H, Morimoto T, Ohishi M, Kimura T on behalf of the CREDO-Kyoto PCI/ CABG registry cohort-2 investigators.
• Incidence and Outcome of Surgical Procedures After Coronary Artery Bypass Grafting Compared With Those After Percutaneous Coronary Intervention: a report from the CREDO-Kyoto PCI/CABG registry cohort-2.
• Yoshimura A, Oketani N, Iriki Y, Okui H, Ichiki H, Maenosono R, Namino F, Miyata M, Hamasaki S, Ohishi M.
• Atrial fibrillation termination caused by pulmonary vein isolation prior to complex fractionated atrial electrograms guided ablation.
• 17th Annual Scientific Meeting of Heart Failure Society of America (HFSA)
  (2014年9月, Las Vegas, USA)
• Ichiki T, Huntley BK, Sangaralingham SJ, Harty GJ, and Burnett JC, Jr.
• Gene Expression Profiling in Experimental Early Stage Heart Failure Reveals Activation of Molecular Pathways of Fibrosis and Inflammation in the Kidney and Heart.
• Sangaralingham SJ, Huntley BK, Harders GE, Ichiki T, and Burnett JC, Jr.
• The Guanylyl Cyclase Receptor B and Cyclic GMP Activating Actions of a Unique Molecular Form of C-Type Natriuretic Peptide In Vitro and In Vivo.
• Puccia G, Sangraralingham SJ, Harty G, Cataliotti A, Ichiki T, Malatino L, and Burnett JC, Jr.
• M-Atrial Natriuretic Peptide: A Novel Designer Natriuretic Peptide with Sustained Blood Pressure Lowering and Cyclic GMP Activating Actions in a Chronic Canine Model of Angiotensin II-Induced Hypertension.
• American Heart Association (AHA)
  (2014年11月, Chicago, USA)
• Ikeda Y, Maejima Y, Ohishi M, Sadoshima J.
• Mitochondrial fission plays a crucial role in cardiomyocyte adaptation to energy stress via mitophagy.
• Ikeda Y, Zhai P, Ohishi M, Sadoshima J.
• Prolonged inhibition of mitochondrial fission enhances myocardial injury in response to ischemia/reperfusion.
• Ichiki T, Huntley BK, Sangaralingham SJ, Harty GJ, and Burnett JC, Jr.
• Atrium Fibrosis and Inflammation: Impaired Atrial Natriuretic Peptide System in Experimental Heart Failure.
• Ichiki T, Huntley BK, Andersen IA, Sangaralingham SJ, Harty GJ, Sandberg SM, Heublein DM, and Burnett JC, Jr.
• Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator Which Goes Beyond Carperitide and Nesiritide.
• Ichiki T, Huntley BK, Sangaralingham SJ, Harty GJ, and Burnett JC, Jr.
• Widespread Activation of Kidney Injury and Remodeling Molecular Pathways in Experimental Heart Failure in Canines.
• Sangaralingham SJ, Huntley BK, Ichiki T, Sandberg SM, and Burnett JC, Jr.
• Human C-Type Natriuretic Peptide-53: A Distinct Molecular Form With in vitro and in vivo Biological Actions Through cGMP Generation.
• Sangaralingham SJ, Ichiki T, Harders GE, Chen HH, and Burnett JC, Jr.
• Impairment of the Compensatory Natriuretic Peptide Response to Myocardial Infarction in the Aged is Associated With Adverse Cardiorenal Repair and Heart Failure.
• Puccia G, Sangraralingham SJ, Harty G, Cataliotti A, Ichiki T, Malatino L, and Burnett JC, Jr.
• Antihypertensive Properties of Subcutaneous M-ANP, a Novel Designer Atrial Natriuretic Peptide, in a Canine Model of Chronic Angiotensin-II Induced Hypertension.
• Miyauchi T, Ikeda Y, Akasaki Y, Iwabayashi M, Sasaki Y, Miyata M, Ohishi M.
• Selective estrogen receptor modulator retards arterial senescence and atherosclerosis through restoration of down-regulated Sirt-1 in post-menopause model mouse.
• Kawasoe S, Kubozono T, Miyata M, Yamaguchi T, Torii H, Ohishi M.
• The Blood Glucose Concentration at Hospitalization is a Significant Predictor of In-hospital Death in the Patients with Non-diabetic Acute Decompensated Heart Failure.
• Zhai P, Ikeda Y, Shirakabe A, Yamamoto T, Magrys B, Cheng X, Sadoshima J.
• Constitutively Active GSK-3β Attenuates Cardiac Aging through Ulk1-dependent Stimulation of Autophagy.
• Shirakabe A, Ikeda Y, Zai P, Sadoshima J.
• Drp1 accumulates in mitochondria and plays a protective role in the heart in response to pressure overload.
• Oka S, Zhai P, Yamamoto T, Ikeda Y, Sadoshima J.
• PPARalpha/Sirt1 heterodimer suppresses fatty acid oxidation genes in the heart under pressure overload.